Nexvet Biopharma Ord (NVET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,526 | -10,507 | -5,095 | -19,365 | -15,396 |
| Depreciation Amortization | 624 | 397 | 196 | 516 | 323 |
| Other Working Capital | -2,629 | -1,781 | -1,954 | 2,304 | 3,498 |
| Other Operating Activity | 1,769 | 921 | 469 | 1,762 | 1,351 |
| Operating Cash Flow | $-16,762 | $-10,970 | $-6,384 | $-14,783 | $-10,224 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -860 | -818 | -553 | -4,927 | -3,954 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -64 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -64 | 0 |
| Investing Cash Flow | $-860 | $-818 | $-553 | $-4,991 | $-3,954 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 38 | 23 | 20 | 20 | 19 |
| Financing Cash Flow | $38 | $23 | $20 | $20 | $19 |
| Exchange Rate Effect | 624 | 766 | -14 | -798 | -712 |
| Beginning Cash Position | 31,481 | 31,481 | 31,481 | 52,033 | 52,033 |
| End Cash Position | 14,521 | 20,482 | 24,550 | 31,481 | 37,162 |
| Net Cash Flow | $-16,960 | $-10,999 | $-6,931 | $-20,552 | $-14,871 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,762 | -10,970 | -6,384 | -14,783 | -10,224 |
| Capital Expenditure | -860 | -818 | -553 | -4,927 | -3,954 |
| Free Cash Flow | -17,622 | -11,788 | -6,937 | -19,710 | -14,178 |